Full Press Release Details
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development.
ZYME
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
Key Takeaway: Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
Price reaction · baseline $11.53 (2025-04-17 close) · clean, no other ZYME news in the window
day 0 close · peak
+1.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers